middle.news
Genetic Signatures and Microba Explore Merger to Expand Infectious Disease Diagnostics
9:30am on Wednesday 26th of August, 2026 AEST
•
Healthcare
Read Story
Genetic Signatures and Microba Explore Merger to Expand Infectious Disease Diagnostics
9:30am on Wednesday 26th of August, 2026 AEST
Key Points
Potential merger to create leading infectious disease diagnostics group
Combined FY2026 revenue estimated at A$29 million
Broader market access across Australia, UK, and Europe
Complementary GI diagnostic product portfolios
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE